Filed: 8/14/2024ACC: 0001104659-24-089657
📋 What this filing means
NORTHPOND VENTURES, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $55.27M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$55.27M
Total AUM (reported)
9.95M
Total Shares
Allocation by class
COM$53.27M96.4%
COM NEW$2.00M3.6%
Portfolio Concentration
Top 3$53.27M96.4%
4–10$2.00M3.6%
Top 3 weight
96.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.95M
Sole
Full voting authority
9.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
KYVERNA THERAPEUTICS INC
SOLEShares3.26M
TypeSH
Market value$24.42M
44.18%
Sole
3.26M
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares4.21M
TypeSH
Market value$16.86M
30.50%
Sole
4.21M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$12.00M
21.71%
Sole
1.94M
Shared
0.00
None
0.00
TELESIS BIO INC
SOLEShares546.90K
TypeSH
Market value$2.00M
3.61%
Sole
546.90K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KYVERNA THERAPEUTICS INCSOLE | COM | 3.26M | SH | $24.42M 44.18% | 3.26M | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 4.21M | SH | $16.86M 30.50% | 4.21M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $12.00M 21.71% | 1.94M | 0.00 | 0.00 |
TELESIS BIO INCSOLE | COM NEW | 546.90K | SH | $2.00M 3.61% | 546.90K | 0.00 | 0.00 |